Vagus nerve stimulation delivers electrical pulses to the nerve linking brain, heart, gut and immune system, via implants for specific diseases or neck and ear devices, some sold for wellness. Best-supported benefits are disease-specific: epilepsy, stroke recovery, rheumatoid arthritis, headache, irregular heart rhythm. For healthy adults, ear devices modestly aid laboratory thinking tasks and self-rated sleep; lower inflammation is unproven. Implants carry surgical and voice risks; makers fund most trials. (Full Review)

Protocol

Ear regimen for AF

Tragus ear clip, 20 Hz, 1 hour daily

1 mA below the discomfort threshold, over 6 months

Ear regimen for autonomic function

Tragus clips, 30 Hz, 200 µs, 15 minutes daily

Intensity turned down to just perceptible; two weeks in adults aged 55 or older

Implanted epilepsy regimen

30-second trains at 30 Hz every 5 minutes

500 µs pulses; output raised over weeks to the tolerated level

Time to effect

Less time in atrial fibrillation

By 6 months

Daily tragus ear-clip stimulation

Acute headache relief

Within 30 minutes

Non-invasive neck stimulation

Rheumatoid arthritis response

By 3 months

Implanted neck stimulation

Benefits

High: Fewer seizures in drug-resistant focal epilepsy

Medium: Upper-limb motor recovery after ischemic stroke; less time in atrial fibrillation; better heart function and walking capacity in heart failure; relief of functional dyspepsia; rheumatoid arthritis disease activity; headache pain in migraine, cluster headache and hemicrania; better performance on cognitive tasks; better sleep quality; motor symptoms in Parkinson's disease; pain relief

Low: Depressive symptoms; autonomic balance in older adults; lower blood pressure; lower body weight gain; chronic constipation relief; tinnitus severity; recovery of consciousness after severe brain injury

Speculative: Lower systemic inflammation; slower biological aging

Contraindications

Bilateral or left cervical vagotomy: Implanted stimulation is contraindicated

People requiring diathermy treatment: Implanted stimulation is contraindicated

Active implantable electronic devices (pacemaker, defibrillator, hearing implant): Neck non-invasive stimulation is contraindicated

Clinically significant bradycardia, tachycardia, hypertension or hypotension; carotid atherosclerosis; metal implants at the neck: Neck non-invasive stimulation has not been evaluated in these groups

Sustained bradycardia (heart rate below 50 beats per minute) or chronotropic incompetence: Excluded from heart-rate-triggered implant stimulation

Pregnancy: Safety is not established for implanted or neck devices

Untreated obstructive sleep apnea or pre-existing swallowing difficulty: Higher risk of breathing pauses and inhaling food or fluid into the airways with implanted stimulation

Key Interactions

Magnetic resonance imaging (MRI): Lead heating can cause serious injury; scans limited to the manufacturer's MRI guidance

Beta-adrenergic blockers (such as metoprolol, propranolol) and pacemaker dependency: Heart-rate-triggered AutoStim mode unsuitable

Pacemakers, implantable defibrillators and other stimulators: Possible sensing problems; devices at least 10 cm apart

External defibrillation or cardioversion: Can damage the generator and the nerve

Transcutaneous electrical nerve stimulation (TENS) and other stimulators: Combined currents can disrupt stimulation; simultaneous use with neck non-invasive stimulation contraindicated

Theoretical (inferred from mechanism)

Cholinesterase inhibitors (such as donepezil, galantamine, pyridostigmine): Could deepen bradycardia during stimulation

Heart-rate-lowering drugs (digoxin, verapamil, amiodarone): Could cause symptomatic bradycardia

Sedatives and opioids (alprazolam, zolpidem, oxycodone): Could worsen implant-related sleep apnea

Anticholinergic drugs (such as oxybutynin, amitriptyline, scopolamine): Could blunt the anti-inflammatory and heart-rate effects of stimulation

Over-the-counter sedating antihistamines (diphenhydramine, doxylamine): Could blunt stimulation effects and add to sleep-disordered breathing with implants

Nicotine replacement (gum, patches): Anti-inflammatory effects could overlap and confound assessment

Cholinergic supplements (such as huperzine A, alpha-GPC, citicoline): Could add to heart-rate slowing

Supplements with additive heart-rate or blood-pressure lowering (hawthorn, high-dose omega-3 fatty acids, magnesium): Could cause lightheadedness during sessions

Vagal maneuvers and slow-breathing practices (cold-water face immersion, slow-paced breathing): Could cause dizziness or marked heart-rate slowing

Risk & Side Effects

High: Voice alteration and shortness of breath during stimulation

Medium: Surgical and device complications; tingling, pain, throat, digestive and other symptoms from implants

Low: Sleep-disordered breathing; bradycardia and asystole around implantation; worsening depression and suicidal thoughts; local and neurological sensations from non-invasive devices

Speculative: Nerve damage from excessive stimulation; triggering atrial fibrillation at high intensity; blunted immune defense

Monitoring

Marker	Target	Why
Resting heart rate	60–100 beats per minute	Safety check: stimulation can slow the heart
Serum potassium, magnesium, calcium	Potassium 3.5–5.0 mmol/L, magnesium 1.7–2.2 mg/dL, calcium 8.5–10.5 mg/dL	Safety check before implantation
Apnea-hypopnea index	Below 5 events per hour	Safety check: implants can trigger sleep apnea
Resting ECG	Not specified in the ER	Baseline check before an implant
Blood pressure	Not specified in the ER	Screening before neck non-invasive stimulation

Cadence: Baseline resting ECG, electrolytes, magnesium and calcium before an implant; blood pressure and resting heart rate before neck non-invasive stimulation; a week of morning resting heart rate readings before ear devices. Resting heart rate weekly during the first month, then monthly; repeat sleep evaluation within 3 months of implant activation or any setting increase; disease-specific measures follow the treating specialist's schedule.

Qualitative Assessment

Sleep quality and daytime alertness
Mood, stress resilience and energy levels
Cognitive clarity and focus during demanding tasks
Symptom diaries for the targeted condition (seizures, headache days, joint pain, palpitations)
Voice changes, cough, swallowing comfort and ear or neck skin irritation

Vagus Nerve Stimulation for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment